Unternehmen in BERLIN

TP21 GMBH

BeobachtenFeed abonnierenFörderungen als CSV

In 0 Bekanntmachungen genannt, seit 1. Januar 2009, aber in keiner als Auftragnehmer eines Zuschlags.

Fördermittel

Kohesio und Finanztransparenzsystem der EU, so gezählt.

28 Förderungen, zusammen 5,8 Mio. €.

QuelleBetragFörderungen
EU-Haushalt (Finanztransparenzsystem)5,8 Mio. €2828
JahrProgrammProjektBetrag und Beleg
2024EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101057655 - AISN - INTEGRATING AI IN STROKE NEUROREHABILITATION101057655 - AISN - INTEGRATING AI IN STROKE NEUROREHABILITATION31.256 €Mittelbindung
2023EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101079777 - MICROB-AI-OME - FEDERATED ARTIFICIAL INTELLIGENCE FOR PRIVACY-PRESERVING INTERNATIONAL STRATIFICATION OF COLORECTAL CANCER PATIENTS101079777 - MICROB-AI-OME - FEDERATED ARTIFICIAL INTELLIGENCE FOR PRIVACY-PRESERVING INTERNATIONAL STRATIFICATION OF COLORECTAL CANCER PATIENTS206.667 €Mittelbindung
2023EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101079777 - MICROB-AI-OME - FEDERATED ARTIFICIAL INTELLIGENCE FOR PRIVACY-PRESERVING INTERNATIONAL STRATIFICATION OF COLORECTAL CANCER PATIENTS101079777 - MICROB-AI-OME - FEDERATED ARTIFICIAL INTELLIGENCE FOR PRIVACY-PRESERVING INTERNATIONAL STRATIFICATION OF COLORECTAL CANCER PATIENTS193.333 €Mittelbindung
2023EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101104582 - INTREALL 2020 - INTERNATIONAL STUDY FOR TREATMENT OF CHILDHOOD RELAPSED ALL 2020101104582 - INTREALL 2020 - INTERNATIONAL STUDY FOR TREATMENT OF CHILDHOOD RELAPSED ALL 2020266.793 €Mittelbindung
2023EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101104582 - INTREALL 2020 - INTERNATIONAL STUDY FOR TREATMENT OF CHILDHOOD RELAPSED ALL 2020101104582 - INTREALL 2020 - INTERNATIONAL STUDY FOR TREATMENT OF CHILDHOOD RELAPSED ALL 202051.954 €Mittelbindung
2023EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101136305 - DAIBETES - FEDERATED VIRTUAL TWINS FOR PRIVACY-PRESERVING PERSONALISED OUTCOME PREDICTION OF TYPE 2 DIABETES TREATMENT101136305 - DAIBETES - FEDERATED VIRTUAL TWINS FOR PRIVACY-PRESERVING PERSONALISED OUTCOME PREDICTION OF TYPE 2 DIABETES TREATMENT231.391 €Mittelbindung
2023EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101136305 - DAIBETES - FEDERATED VIRTUAL TWINS FOR PRIVACY-PRESERVING PERSONALISED OUTCOME PREDICTION OF TYPE 2 DIABETES TREATMENT101136305 - DAIBETES - FEDERATED VIRTUAL TWINS FOR PRIVACY-PRESERVING PERSONALISED OUTCOME PREDICTION OF TYPE 2 DIABETES TREATMENT175.608 €Mittelbindung
2023EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101137221 - EPIC - ENHANCING PALLIATIVE CARE IN ICU101137221 - EPIC - ENHANCING PALLIATIVE CARE IN ICU175.631 €Mittelbindung
2023EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101137221 - EPIC - ENHANCING PALLIATIVE CARE IN ICU101137221 - EPIC - ENHANCING PALLIATIVE CARE IN ICU234.622 €Mittelbindung
2022EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101057123 - BE-SAFE - IMPLEMENTING A PATIENT-CENTRED AND EVIDENCE-BASED INTERVENTION TO REDUCE BENZODIAZEPINE AND SEDATIVE-HYPNOTIC USE TO IMPROVE PATIENT SAFETY AND QUALITY OF CARE101057123 - BE-SAFE - IMPLEMENTING A PATIENT-CENTRED AND EVIDENCE-BASED INTERVENTION TO REDUCE BENZODIAZEPINE AND SEDATIVE-HYPNOTIC USE TO IMPROVE PATIENT SAFETY AND QUALITY OF CARE127.532 €Mittelbindung
2022EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101057123 - BE-SAFE - IMPLEMENTING A PATIENT-CENTRED AND EVIDENCE-BASED INTERVENTION TO REDUCE BENZODIAZEPINE AND SEDATIVE-HYPNOTIC USE TO IMPROVE PATIENT SAFETY AND QUALITY OF CARE101057123 - BE-SAFE - IMPLEMENTING A PATIENT-CENTRED AND EVIDENCE-BASED INTERVENTION TO REDUCE BENZODIAZEPINE AND SEDATIVE-HYPNOTIC USE TO IMPROVE PATIENT SAFETY AND QUALITY OF CARE18.219 €Mittelbindung
2022EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101057123 - BE-SAFE - IMPLEMENTING A PATIENT-CENTRED AND EVIDENCE-BASED INTERVENTION TO REDUCE BENZODIAZEPINE AND SEDATIVE-HYPNOTIC USE TO IMPROVE PATIENT SAFETY AND QUALITY OF CARE101057123 - BE-SAFE - IMPLEMENTING A PATIENT-CENTRED AND EVIDENCE-BASED INTERVENTION TO REDUCE BENZODIAZEPINE AND SEDATIVE-HYPNOTIC USE TO IMPROVE PATIENT SAFETY AND QUALITY OF CARE218.626 €Mittelbindung
2022EU Budget - European CommissionREA - European Research Executive Agency101058516 - EBRAIN-HEALTH - EBRAIN-HEALTH - ACTIONABLE MULTILEVEL HEALTH DATA101058516 - EBRAIN-HEALTH - EBRAIN-HEALTH - ACTIONABLE MULTILEVEL HEALTH DATA334.998 €Mittelbindung
2022EU Budget - European CommissionEISMEA - Eur.Innov.Coun. & SMEs EA101071178 - CAVAA - COUNTERFACTUAL ASSESSMENT AND VALUATION FOR AWARENESS ARCHITECTURE101071178 - CAVAA - COUNTERFACTUAL ASSESSMENT AND VALUATION FOR AWARENESS ARCHITECTURE210.000 €Mittelbindung
2022EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101057655 - AISN - INTEGRATING AI IN STROKE NEUROREHABILITATION101057655 - AISN - INTEGRATING AI IN STROKE NEUROREHABILITATION160.177 €Mittelbindung
2022EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101057655 - AISN - INTEGRATING AI IN STROKE NEUROREHABILITATION101057655 - AISN - INTEGRATING AI IN STROKE NEUROREHABILITATION149.823 €Mittelbindung
2018EU Budget - European CommissionCNECT - Directorate-General for Communications Networks, Content and Technology826421 - VIRTUALBRAINCLOUD - PERSONALIZED RECOMMENDATIONS FOR NEURODEGENERATIVE DISEASE826421 - VIRTUALBRAINCLOUD - PERSONALIZED RECOMMENDATIONS FOR NEURODEGENERATIVE DISEASE376.249 €Mittelbindung
2018EU Budget - European CommissionRTD - Directorate-General for Research and Innovation825730 - ENDOSCAPE - ENDOSCAPE, A CLINICALLY APPLICABLE NON-VIRAL GENE DELIVERY TECHNOLOGY825730 - ENDOSCAPE - ENDOSCAPE, A CLINICALLY APPLICABLE NON-VIRAL GENE DELIVERY TECHNOLOGY359.201 €Mittelbindung
2018EU Budget - European CommissionRTD - Directorate-General for Research and Innovation825730 - ENDOSCAPE - ENDOSCAPE, A CLINICALLY APPLICABLE NON-VIRAL GENE DELIVERY TECHNOLOGY825730 - ENDOSCAPE - ENDOSCAPE, A CLINICALLY APPLICABLE NON-VIRAL GENE DELIVERY TECHNOLOGY10.802 €Mittelbindung
2016EU Budget - European CommissionCNECT - Directorate-General for Communications Networks, Content and Technology732411 - PAMMOTH - PHOTOACOUSTIC/ULTRASOUND MAMMOSCOPY FOR EVALUATING SCREENING-DETECTED ABNORMALITIES IN THE BREAST732411 - PAMMOTH - PHOTOACOUSTIC/ULTRASOUND MAMMOSCOPY FOR EVALUATING SCREENING-DETECTED ABNORMALITIES IN THE BREAST222.500 €Mittelbindung
2016EU Budget - European CommissionCNECT - Directorate-General for Communications Networks, Content and Technology731771 - CVENT - RISK ASSESSMENT OF PLAQUE RUPTURE AND FUTURE CARDIOVASCULAR EVENTS (CVENT) BY MULTI-SPECTRAL PHOTOACOUSTIC IMAGING731771 - CVENT - RISK ASSESSMENT OF PLAQUE RUPTURE AND FUTURE CARDIOVASCULAR EVENTS (CVENT) BY MULTI-SPECTRAL PHOTOACOUSTIC IMAGING223.750 €Mittelbindung
2015EU Budget - European CommissionRTD - Directorate-General for Research and Innovation634238 - OPERAM - OPTIMISING THERAPY TO PREVENT AVOIDABLE HOSPITAL ADMISSIONS IN THE MULTIMORBID ELDERLY634238 - OPERAM - OPTIMISING THERAPY TO PREVENT AVOIDABLE HOSPITAL ADMISSIONS IN THE MULTIMORBID ELDERLY269.000 €Mittelbindung
2015EU Budget - European CommissionRTD - Directorate-General for Research and Innovation681094 - NISCI - ANTIBODIES AGAINST NOGO-A TO ENHANCE PLASTICITY, REGENERATION AND FUNCTIONAL RECOVERY AFTER ACUTE SPINAL CORD INJURY, A MULTICENTER EUROPEAN CLINICAL PROOF OF CONCEPT TRIAL681094 - NISCI - ANTIBODIES AGAINST NOGO-A TO ENHANCE PLASTICITY, REGENERATION AND FUNCTIONAL RECOVERY AFTER ACUTE SPINAL CORD INJURY, A MULTICENTER EUROPEAN CLINICAL PROOF OF CONCEPT TRIAL278.125 €Mittelbindung
2013EU Budget - European CommissionRTD - Directorate-General for Research and InnovationUNIVAXUNIVAX268.000 €Mittelbindung
2012EU Budget - European CommissionRTD - Directorate-General for Research and InnovationGenome-based biomarkers leading to validated molecular diagnostic tests for response prediction in breast cancerGenome-based biomarkers leading to validated molecular diagnostic tests for response prediction in breast cancer288.000 €Mittelbindung

Angaben aus den Bekanntmachungen

0 Nennungen seit 1. Januar 2009, zuletzt am 1. Januar 2009, dieser Organisation zugeordnet. Wie wir zuordnen

Anschrift
LUISENSTRASSE 14, 10117 BERLIN
USt-IdNr.
DE229548135
Schreibweisen
  • TP21 GMBH